AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 128.50 Decreased By ▼ -1.03 (-0.8%)
BOP 6.72 Increased By ▲ 0.04 (0.6%)
CNERGY 4.46 Decreased By ▼ -0.17 (-3.67%)
DCL 8.64 Decreased By ▼ -0.30 (-3.36%)
DFML 40.15 Decreased By ▼ -1.54 (-3.69%)
DGKC 80.40 Decreased By ▼ -3.37 (-4.02%)
FCCL 32.70 Decreased By ▼ -0.07 (-0.21%)
FFBL 74.60 Decreased By ▼ -0.87 (-1.15%)
FFL 11.60 Increased By ▲ 0.13 (1.13%)
HUBC 109.21 Decreased By ▼ -1.34 (-1.21%)
HUMNL 13.95 Decreased By ▼ -0.61 (-4.19%)
KEL 5.35 Decreased By ▼ -0.04 (-0.74%)
KOSM 7.95 Decreased By ▼ -0.45 (-5.36%)
MLCF 38.50 Decreased By ▼ -1.29 (-3.24%)
NBP 63.48 Increased By ▲ 3.19 (5.29%)
OGDC 195.70 Decreased By ▼ -3.96 (-1.98%)
PAEL 25.84 Decreased By ▼ -0.81 (-3.04%)
PIBTL 7.40 Decreased By ▼ -0.26 (-3.39%)
PPL 155.80 Decreased By ▼ -2.12 (-1.34%)
PRL 25.60 Decreased By ▼ -1.13 (-4.23%)
PTC 17.20 Decreased By ▼ -1.26 (-6.83%)
SEARL 78.00 Decreased By ▼ -4.44 (-5.39%)
TELE 7.88 Decreased By ▼ -0.43 (-5.17%)
TOMCL 33.20 Decreased By ▼ -1.31 (-3.8%)
TPLP 8.39 Decreased By ▼ -0.67 (-7.4%)
TREET 16.50 Decreased By ▼ -0.97 (-5.55%)
TRG 57.52 Decreased By ▼ -3.80 (-6.2%)
UNITY 27.50 Increased By ▲ 0.07 (0.26%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,409 Increased By 2.6 (0.03%)
BR30 31,124 Decreased By -589.4 (-1.86%)
KSE100 97,804 Increased By 475.7 (0.49%)
KSE30 30,478 Increased By 285.3 (0.94%)

AstraZeneca has suspended investments in Britain due to the lack of clarity over the country's departure from the European Union, the pharmaceutical firm's non-executive chairman Leif Johansson told France's Le Monde newspaper. British Prime Minister Theresa May was facing growing pressure on Monday to rethink her plan for leaving the EU after Brexit talks reached a stand-off at the weekend over arrangements for the UK border with Ireland.
"If a transition deal does not make clear what will happen in the future, we will maintain our decision not to invest," Le Monde quoted Johansson as saying in an interview. "A Brexit agreement will need to ensure that Britain does not become an isolated island in the middle of the Atlantic Ocean," he added. AstraZeneca has already spent 40 million pounds ($53 million) stockpiling medicines in Britain and continental Europe to prevent supply disruptions if the two sides fail to reach a withdrawal agreement.
Some pharmaceutical companies including AstraZeneca have warned of medicine shortages in the event of a 'no deal' Brexit. More than 2,600 drugs have some part of their manufacturing carried out in Britain. Britain exports some 45 million medical packs to EU countries each month, industry figures show, while 37 million flow to Britain from the EU. France's largest drugmaker Sanofi said in August it would increase medicine stockpiles in Britain, echoing moves made by GlaxoSmithKline, Roche and Novartis.

Copyright Reuters, 2018

Comments

Comments are closed.